IS6694A - 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum - Google Patents

4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum

Info

Publication number
IS6694A
IS6694A IS6694A IS6694A IS6694A IS 6694 A IS6694 A IS 6694A IS 6694 A IS6694 A IS 6694A IS 6694 A IS6694 A IS 6694A IS 6694 A IS6694 A IS 6694A
Authority
IS
Iceland
Prior art keywords
mtk
disorders
treatment
indole derivatives
derivatives useful
Prior art date
Application number
IS6694A
Other languages
English (en)
Inventor
Bang-Andersen Benny
Kehler Jan
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS6694A publication Critical patent/IS6694A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IS6694A 2000-08-18 2003-01-20 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum IS6694A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001229 2000-08-18
PCT/DK2001/000547 WO2002016349A1 (en) 2000-08-18 2001-08-17 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
IS6694A true IS6694A (is) 2003-01-20

Family

ID=8159658

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6694A IS6694A (is) 2000-08-18 2003-01-20 4-, 5-, 6- og 7-indólafleiður sem eru nytsamlegarvið meðhöndlun á MTK-truflunum

Country Status (29)

Country Link
US (2) US6958338B2 (is)
EP (1) EP1309586B1 (is)
JP (1) JP2004506731A (is)
KR (1) KR20030022363A (is)
CN (1) CN1243750C (is)
AR (1) AR030357A1 (is)
AT (1) ATE321040T1 (is)
AU (2) AU7961101A (is)
BG (1) BG107611A (is)
BR (1) BR0113452A (is)
CA (1) CA2419266A1 (is)
CZ (1) CZ2003461A3 (is)
DE (1) DE60118205T2 (is)
DK (1) DK1309586T3 (is)
EA (1) EA006155B1 (is)
ES (1) ES2257424T3 (is)
HR (1) HRP20030052A2 (is)
HU (1) HUP0302777A2 (is)
IL (1) IL154051A0 (is)
IS (1) IS6694A (is)
MX (1) MXPA03000838A (is)
NO (1) NO20030522D0 (is)
NZ (1) NZ523786A (is)
PL (1) PL363309A1 (is)
PT (1) PT1309586E (is)
SK (1) SK3212003A3 (is)
UA (1) UA74837C2 (is)
WO (1) WO2002016349A1 (is)
ZA (1) ZA200300562B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099828A1 (ja) * 2006-02-23 2007-09-07 Shionogi & Co., Ltd. 環式基で置換された含窒素複素環誘導体
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US7776905B2 (en) 2006-04-07 2010-08-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
TWI404702B (zh) * 2007-08-31 2013-08-11 Lundbeck & Co As H 兒茶酚胺衍生物和其前藥
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
CN105130948A (zh) 2010-04-22 2015-12-09 弗特克斯药品有限公司 制备环烷基甲酰胺基-吲哚化合物的方法
CA2878057A1 (en) 2012-07-16 2014-01-23 Rossitza Gueorguieva Alargova Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
JO3425B1 (ar) 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
JP6543268B2 (ja) 2014-04-15 2019-07-10 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 嚢胞性線維症膜コンダクタンス調節因子が媒介する疾患を処置するための医薬組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421641A1 (de) * 1984-06-09 1985-12-12 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
AU6215594A (en) * 1993-03-18 1994-10-11 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
CA2188949A1 (en) * 1994-04-28 1995-11-09 Janusz Jozef Kulagowski Benzofuran derivatives as d4 receptor antagonists
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
GB9520731D0 (en) * 1995-10-10 1995-12-13 Merck Sharp & Dohme Therapeutic agents
GB9604036D0 (en) * 1996-02-26 1996-04-24 Merck Sharp & Dohme Therapeutic agents
DE69934093T2 (de) * 1998-01-27 2007-06-21 Aventis Pharmaceuticals Inc. SUBSTITUIERTE OXOAZAHETEROCYCLYL FAKTOR Xa HEMMER
KR100681724B1 (ko) * 1999-10-19 2007-02-28 머크 앤드 캄파니 인코포레이티드 티로신 키나제 억제제 및 이를 포함하는 약제학적 조성물
US6727264B1 (en) * 2001-07-05 2004-04-27 Synaptic Pharmaceutical Corporation Substituted anilinic piperidines as MCH selective antagonists

Also Published As

Publication number Publication date
CZ2003461A3 (cs) 2003-05-14
US20030166665A1 (en) 2003-09-04
ATE321040T1 (de) 2006-04-15
PT1309586E (pt) 2006-06-30
BG107611A (bg) 2003-12-31
CA2419266A1 (en) 2002-02-28
CN1243750C (zh) 2006-03-01
BR0113452A (pt) 2003-07-15
PL363309A1 (en) 2004-11-15
JP2004506731A (ja) 2004-03-04
EP1309586B1 (en) 2006-03-22
UA74837C2 (en) 2006-02-15
US7105543B2 (en) 2006-09-12
MXPA03000838A (es) 2003-06-06
EP1309586A1 (en) 2003-05-14
DE60118205T2 (de) 2006-11-02
NO20030522L (no) 2003-02-03
US20060004022A1 (en) 2006-01-05
IL154051A0 (en) 2003-07-31
KR20030022363A (ko) 2003-03-15
DK1309586T3 (da) 2006-07-10
US6958338B2 (en) 2005-10-25
DE60118205D1 (de) 2006-05-11
ZA200300562B (en) 2004-08-23
HK1059438A1 (en) 2004-07-02
EA200300278A1 (ru) 2003-06-26
HRP20030052A2 (en) 2005-02-28
CN1447806A (zh) 2003-10-08
NZ523786A (en) 2005-07-29
ES2257424T3 (es) 2006-08-01
AR030357A1 (es) 2003-08-20
AU2001279611B2 (en) 2006-08-10
HUP0302777A2 (hu) 2003-12-29
SK3212003A3 (en) 2003-07-01
WO2002016349A1 (en) 2002-02-28
AU7961101A (en) 2002-03-04
NO20030522D0 (no) 2003-02-03
EA006155B1 (ru) 2005-10-27

Similar Documents

Publication Publication Date Title
NO20032801D0 (no) Tiazolderivater for behandling av PPAR relaterte forstyrrelser
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
CY2009001I1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
IS6837A (is) 3-Indólín afleiður sem eru nytsamlegar við meðhöndlun á geðrænum og taugafræðilegum truflunum
MXPA03000838A (es) Derivados 4-, 5-, 6- y 7-indol utiles para el tratamiento de transtornos del snc.
IS6438A (is) Nýjar asabísýklóoktanafleiður sem eru gagnlegar við meðhöndlun á hjartsláttartruflunum
IS6663A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
IS6642A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20026005L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
IS6098A (is) Ósantant til meðhöndlunar á skaptruflunum
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
IS6652A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
IS6643A (is) Indólafleiður sem eru nytsamlegar við meðhöndlun á MTK-truflunum
NO20025760D0 (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
NO20026028L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
SI1309586T1 (sl) Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns
DK1157987T3 (da) S-nitrosothioler som midler til behandling af kredsløbsforstyrrelser
IS6199A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
IS6198A (is) Ný bispidín efnasambönd sem eru gagnleg við meðhöndlun á hjartsláttarglöpum
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders